» Articles » PMID: 38419039

Association Between Different Insulin Resistance Surrogates and All-cause Mortality in Patients with Coronary Heart Disease and Hypertension: NHANES Longitudinal Cohort Study

Overview
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Studies on the relationship between insulin resistance (IR) surrogates and long-term all-cause mortality in patients with coronary heart disease (CHD) and hypertension are lacking. This study aimed to explore the relationship between different IR surrogates and all-cause mortality and identify valuable predictors of survival status in this population.

Methods: The data came from the National Health and Nutrition Examination Survey (NHANES 2001-2018) and National Death Index (NDI). Multivariate Cox regression and restricted cubic splines (RCS) were performed to evaluate the relationship between homeostatic model assessment of IR (HOMA-IR), triglyceride glucose index (TyG index), triglyceride glucose-body mass index (TyG-BMI index) and all-cause mortality. The recursive algorithm was conducted to calculate inflection points when segmenting effects were found. Then, segmented Kaplan-Meier analysis, LogRank tests, and multivariable Cox regression were carried out. Receiver operating characteristic (ROC) and calibration curves were drawn to evaluate the differentiation and accuracy of IR surrogates in predicting the all-cause mortality. Stratified analysis and interaction tests were conducted according to age, gender, diabetes, cancer, hypoglycemic and lipid-lowering drug use.

Results: 1126 participants were included in the study. During the median follow-up of 76 months, 455 participants died. RCS showed that HOMA-IR had a segmented effect on all-cause mortality. 3.59 was a statistically significant inflection point. When the HOMA-IR was less than 3.59, it was negatively associated with all-cause mortality [HR = 0.87,95%CI (0.78, 0.97)]. Conversely, when the HOMA-IR was greater than 3.59, it was positively associated with all-cause mortality [HR = 1.03,95%CI (1.00, 1.05)]. ROC and calibration curves indicated that HOMA-IR was a reliable predictor of survival status (area under curve = 0,812). No interactions between HOMA-IR and stratified variables were found.

Conclusion: The relationship between HOMA-IR and all-cause mortality was U-shaped in patients with CHD and hypertension. HOMA-IR was a reliable predictor of all-cause mortality in this population.

Citing Articles

Association between triglyceride glucose index and biological aging in U.S. adults: National Health and Nutrition Examination Survey.

Pan L, Jin L Cardiovasc Diabetol. 2025; 24(1):100.

PMID: 40022176 PMC: 11871761. DOI: 10.1186/s12933-025-02631-w.


Association between the triglyceride glucose-body mass index and mortality risk in cardiovascular disease populations: a longitudinal cohort study.

Chen B, Wang H, Xu S, Zeng D, Liu S, Pan X BMC Public Health. 2025; 25(1):822.

PMID: 40022003 PMC: 11871752. DOI: 10.1186/s12889-025-22018-6.


Associations of prognostic nutritional index with cardiovascular all-cause mortality among CVD patients with diabetes or prediabetes: evidence from the NHANES 2005-2018.

Xu W, Zhang L, Yang Q, Cao Y, Rao R, Lv L Front Immunol. 2025; 16:1518295.

PMID: 40013151 PMC: 11860081. DOI: 10.3389/fimmu.2025.1518295.


Association Between Triglyceride-Glucose Related Index and Endometriosis Varies According to Educational Level.

Lin C, Wu Q, Luo Z, Du J, Hong S, Chae H Nutrients. 2025; 17(4).

PMID: 40004998 PMC: 11858264. DOI: 10.3390/nu17040670.


The weight-adjusted-waist index predicts all-cause and cardiovascular mortality in hypertension.

Zheng Y, Nie Z, Zhang Y, Sun T Front Cardiovasc Med. 2025; 12:1501551.

PMID: 39995963 PMC: 11847816. DOI: 10.3389/fcvm.2025.1501551.


References
1.
Kurl S, Zaccardi F, Onaemo V, Jae S, Kauhanen J, Ronkainen K . Association between HOMA-IR, fasting insulin and fasting glucose with coronary heart disease mortality in nondiabetic men: a 20-year observational study. Acta Diabetol. 2014; 52(1):183-6. DOI: 10.1007/s00592-014-0615-x. View

2.
Lee J, Jeon S, Joung B, Lee H, Kwon Y . Associations of Homeostatic Model Assessment for Insulin Resistance Trajectories With Cardiovascular Disease Incidence and Mortality. Arterioscler Thromb Vasc Biol. 2023; 43(9):1719-1728. DOI: 10.1161/ATVBAHA.123.319200. View

3.
Peng N, Kuang M, Peng Y, Yu H, Zhang S, Xie G . Associations between TyG-BMI and normal-high blood pressure values and hypertension: cross-sectional evidence from a non-diabetic population. Front Cardiovasc Med. 2023; 10:1129112. PMC: 10164981. DOI: 10.3389/fcvm.2023.1129112. View

4.
An X, Yu D, Zhang R, Zhu J, Du R, Shi Y . Insulin resistance predicts progression of de novo atherosclerotic plaques in patients with coronary heart disease: a one-year follow-up study. Cardiovasc Diabetol. 2012; 11:71. PMC: 3441242. DOI: 10.1186/1475-2840-11-71. View

5.
Hill M, Yang Y, Zhang L, Sun Z, Jia G, Parrish A . Insulin resistance, cardiovascular stiffening and cardiovascular disease. Metabolism. 2021; 119:154766. DOI: 10.1016/j.metabol.2021.154766. View